NRX Pharmaceuticals, Inc. Share Price
NRX Pharmaceuticals, Inc. (NRXP) had Share Price of $3.00 per share as of 2025-07-17, per its 10-K filed 2026-03-23.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:SharePrice · last filed 2026-03-23
- 2025-07-17: Share Price $3.00.
- 2021-12-31: Share Price $4.78.
- 2021-09-30: Share Price $9.27.
- 2021-06-30: Share Price $11.62.
| Period end | Share Price | Share Price as first filed |
|---|---|---|
| 2025-07-17 | $3.00 10-K · filed 2026-03-23 | |
| 2021-12-31 | $4.78 10-K · filed 2022-03-31 | |
| 2021-09-30 | $9.27 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $11.62 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $35.42 10-Q · filed 2021-05-21 | |
| 2020-12-31 | $11.62 10-K · filed 2022-03-31 | $24.50 10-K/A · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |